Skip to main content
Log in

Purified moniliformin does not affect the force or rate of contraction of isolated guinea pig atria

  • Short Communication
  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Chronic exposure to moniliformin results in the development of myocardial hypertrophy and degeneration. The cause of this hypertrophy is unknown. However, moniliformin-induced hypoxia or altered function of cardiac pyruvate dehydrogenase, rather than direct cardiostimulation have been proposed as potential mechanisms. Isolated guinea pig atria were used in a cumulative concentration-response model to evaluate the direct effect of moniliformin on the rate and force of atrial contraction. Moniliformin did not affect the rate or force of atrial contraction. These results are consistent with the hypothesis that moniliformin does not have a cardiostimulatory effect. Therefore cardiac stimulation, e.g. stimulation of beta-adrenergic receptors, is unlikely to be the cause of the myocardial hypertrophy observed hi poultry chronically intoxicated with moniliformin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Abbas KH, Mirocha CJ, Vesonder RF, Gunther R. Acute toxic effects of an isolate of moniliformin-producing Fusarium oxysporum and purified moniliformin on rats. Arch Environ Contam Toxicol 1990; 19: 433–436.

    Article  CAS  PubMed  Google Scholar 

  2. Allen NK, Burmeister HR, Weaver GA, and Mirocha CJ. Toxicity of dietary and intravenously administered moniliformin to broiler chickens. Poult Sci 1981; 60: 1415–1417.

    CAS  PubMed  Google Scholar 

  3. Burka LT, Doran J, Wilson BJ. Enzyme inhibition and the toxic action of moniliformin and other vinylogous α ketoacids. Biochem Pharmacol 1982; 31: 79–84.

    Article  CAS  PubMed  Google Scholar 

  4. Burmeister HR, Ciegler A, Vesonder RF. Moniliformin, a metabolite of Fusarium moniliforme NRRL 6322: Purification and toxicity. Appl Environ Microbiol 1979; 37: 11–13.

    CAS  PubMed  Google Scholar 

  5. Burmeister HR, Grove MD, Kwolek WF. Moniliformin and butenolide: Effect on mice of high-level, long-term oral intake. Appl Environ Microbiol 1980; 40: 1142–1144.

    CAS  PubMed  Google Scholar 

  6. Chen L, Tian X, Yang B. A study on the inhibition of rat myocardium glutathione peroxidase and glutathione reductase by moniliformin. Mycopathologia 1990; 110: 119–124.

    Article  CAS  PubMed  Google Scholar 

  7. Cole RJ, Cox RH. Fusarium toxins. In: R. J. Cole, R. H. Cox (eds), Handbook of toxic Fungal Metabolites. New York: Academic Press, 1981: 893–910.

    Google Scholar 

  8. Cole RJ, Kirksey JW, Cutler HG, Doupnik BL, Peckham JC. Toxin from Fusarium moniliforme: effects on plants and animals. Science 1973; 179: 1324–1326.

    Article  CAS  PubMed  Google Scholar 

  9. Deyu Z, Qi F, Xianghzen Y, Chenghe L, Yan P, Qin C. Ultra-structural study of moniliformin induced lesions of myocardium in rats and mice. Biomed Environ Sci 1993; 6: 37–44.

    Google Scholar 

  10. Dhalla NS, Yates JC, Naimark B, Dhalla KS, Beamish RE, Ostadal B. Cardiotoxicity of catecholamines and related agents. In: Acosta D Jr (ed), Cardiovascular Toxicology, 2nd ed. New York: Raven Press, 1992: 239–282.

    Google Scholar 

  11. Di Lisa F, Fan C, Gambassi G, Hogue B, Kudryashova I, Hansford RG. Altered pyruvate dehydrogenase control and mitochondrial free Ca2t+ in hearts of cardiomyopathic hamsters. Am J Physiol 1993; 264: H2188–2197.

    PubMed  Google Scholar 

  12. Gad SC. Acute and chronic evaluation of the cardiovascular toxicity of drugs. In: Acosta D Jr (ed), Cardiovascular Toxicology, 2nd ed. New York: Raven Press, Ltd, 1992: 21–43.

    Google Scholar 

  13. Gathercole PS, Thiel PG, Hofmeyr JHS. Inhibition of pyruvate dehydrogenase complex by moniliformin. Biochem J 1986; 233: 719–723.

    CAS  PubMed  Google Scholar 

  14. Herman EH, Ferrans VJ. Overview of morphologic changes induced by the toxic effects of drugs on the cardiovascular system. In: Baskin SI (ed), Principles of Cardiac Toxicology. Boca Raton: CRC Press, 1991: 607–681.

    Google Scholar 

  15. Joffe AZ. Fusariotoxicoses in laboratory animals. In: Fusarium Species: their Biology and Toxicology. New York: John Wiley and Sons, 1986: 300–344.

    Google Scholar 

  16. Joffe AZ. Principal toxins produced by Fusarium sp. In: Fusarium Species: Their Biology and Toxicology. New York: John Wiley and Sons, 1986: 79–163.

    Google Scholar 

  17. Joffe AZ. Toxic Fusarium species and varieties in nature and in laboratory conditions. In: Fusarium Species: Their Biology and Toxicology. New York: John Wiley and Sons, 1986: 9–78.

    Google Scholar 

  18. Kriek NPJ, Marasas WFO, Steyn PS, van Rensburg SJ, Steyn M. Toxicity of a moniliformin-producing strain of Fusarium moniliforme var. subglutinans isolated from maize. Fd Cosmet Toxicol 1977; 15: 578–587.

    Article  Google Scholar 

  19. Ledoux DR, Bermudez AJ, Rottinghaus GE, Broomhead J, Bennett GA. Effects of feeding Fusarium fujikuroi culture material, containing known levels of moniliformin, in young broiler chicks. Poultry Sci. 1995; 74: 297–305.

    CAS  Google Scholar 

  20. Lili F, Lihong S. Effect of moniliformin on myocardial contractility in rats. Biomed. Environ. Sci. 1991; 4: 290–294.

    Google Scholar 

  21. Mehendale HM. Application of isolated organ perfusion techniques in toxicology. In: Hayes AW (ed), Principles and Methods of Toxicology, 3rd ed. New York: Raven Press, Ltd, 1994: 1157–1200.

    Google Scholar 

  22. Norred WP, Bacon CW, Porter JK, Voss KA. Inhibition of protein synthesis in rat primary hepatocytes by extracts of Fusarium moniliforme-contaminated corn. Fd Chem Toxciol 1990; 28: 89–94.

    Article  CAS  Google Scholar 

  23. Penney DG. The cardiac toxicity of carbon monoxide. In: Baskin SI (ed), Principles of cardiac toxicology. Boca Raton: CRC Press. 1991: 573–605.

    Google Scholar 

  24. Rabie CJ, Marasas WFO, Thiel PG, Lubben A, Vleggaar R. Moniliformin production and toxicity of different Fusarium species from southern Africa. Appl Environ Microbiol 1982; 43: 517–521.

    CAS  PubMed  Google Scholar 

  25. Renwick AG. Unmetabolized compounds. In: Caldwell J, Jakoby WB (eds), Biological Basis of Detoxification. New York, Academic Press. 1983: 151–181.

    Google Scholar 

  26. Sprung J, Cheng EY, Gamulin S, Kamine JP, Bosnjak ZJ. The effect of acute hypothermia and serum potassium concentrations on potassium cardiotoxicosis in anesthetized rats. Acta Anaesthesiol Scand 1992; 36: 825–836.

    Article  CAS  PubMed  Google Scholar 

  27. Sturkie PD. Body fluids: Blood. In: Sturkie PD (ed), Avian Physiology. New York: Springer-Verlag, 1986: 102–120.

    Google Scholar 

  28. Sturkie PD. Heart and circulation: anatomy, hemodynamics, blood pressure, blood flow. In: Sturkie PD (ed), Avian Physiology. New York: Springer-Verlag, 1986: 130–166.

    Google Scholar 

  29. Thiel PG. A molecular mechanism for the toxic action of moniliformin, a mycotoxin produced by Fusarium moniliforme. Biochem Pharmacol 1978; 27: 483–486.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reams, R.Y., Thacker, H.L., Harrington, D.D. et al. Purified moniliformin does not affect the force or rate of contraction of isolated guinea pig atria. Mycopathologia 133, 115–118 (1996). https://doi.org/10.1007/BF00439122

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00439122

Key words

Navigation